ArticleIndian journal of clinical biochemistry : IJCB2025
Evaluation of D-Mannoheptulose and Doxorubicin as Potential Therapeutic Agents for Breast Cancer by Targeting Glycolysis and Inducing Apoptosis.
Article in Indian journal of clinical biochemistry : IJCB, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell culture techniques are the vital basis for the majority of experimental cancer research. Targeting cancer cells metabolism is one of the key strategies for controlling the growth of cancer cells. D-Mannoheptulose (MH) (as Phytotherapy) a specific inhibitor, belonging to hexokinase category, to inhibit glycolysis pathway and Doxorubicin (DXR) (as Chemotherapy) has cytotoxic activity against cancer cells and anti-cancer effects by inducing apoptosis. Evaluating the effect of D-Mannoheptulose and Doxorubicin on the normal and breast cancer cell line by determining their anti-tumor activities. Cell culture of normal human mammary epithelial cells (HMECs) and MCF-7 cell line were achieved by using Minimum Essential Medium (MEM) and RPMI-1640 Medium. D-Mannoheptulose, and Doxorubicin stock and diluted solutions were prepared by using phosphate buffer saline (PBS), and dimethyl sulphoxide (DMSO) respectively. HMECs and MCF7 cell line were treated with MH, and DXR, cytotoxicity ratio was determined by methyl thiazolyl tetrazolium (MTT). The findings of study indicated a substantial increase in the cytotoxicity and antiproliferative effects of MH and DXR depending on the concentration gradient against breast cancer cell lines and IC50 values, while on the other hand, there was no significant cytotoxic effect on normal cells. Results of the study revealed that MH, DXR, can result in inhibiting the growth of breast cancer cell lines. This behaviour was mainly due to the increase in cytotoxicity through inhibiting the glycolysis pathway thereby resulting in apoptosis. This further lead to the decrease in HK activity and hence pyruvate as well as ATP amount. Overall, DXR and MH treatment display effective cytotoxic effects against the studied breast cancer cell lines.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.